World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
57
Citations
14763
World Ranking
3589
National Ranking
1662

Claudio Fiocchi publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Claudio Fiocchi sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 234 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Claudio Fiocchi D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Claudio Fiocchi sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 57 D-Index — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Claudio Fiocchi is affiliated with the Cleveland Clinic Lerner College of Medicine in the United States. Their research primarily focuses on medicine and biochemistry, genetics, and molecular biology, with 62 and 45 publications respectively in these fields.

The main subfields of Claudio Fiocchi's work include genetics, molecular biology, epidemiology, surgery, and oncology. Their scientific contributions span across multiple topics, with a strong emphasis on inflammatory bowel disease, microscopic colitis, gut microbiota and health, and the use of single-cell and spatial transcriptomics techniques. Other notable topics covered in their research are IL-33, ST2, and ILC pathways, celiac disease research and management, and Helicobacter pylori-related gastroenterology studies.

Claudio Fiocchi has published extensively in prominent journals. Frequent publication venues include:

  • Gastroenterology (20 publications)
  • Inflammatory Bowel Diseases (7 publications)
  • Gut (4 publications)
  • Journal of Crohn's and Colitis (4 publications)
  • International Journal of Molecular Sciences (2 publications)

Recent notable papers authored or co-authored by Claudio Fiocchi are:

  • Breaking the therapeutic ceiling in drug development in ulcerative colitis, 2021, The Lancet. Gastroenterology & Hepatology
  • A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19, 2020, PLoS Biology
  • Fibrosis in IBD: from pathogenesis to therapeutic targets, 2024, Gut
  • Activated intestinal muscle cells promote preadipocyte migration: a novel mechanism for creeping fat formation in Crohn's disease, 2021, Gut
  • Stricturing Crohn's Disease Single-Cell RNA Sequencing Reveals Fibroblast Heterogeneity and Intercellular Interactions, 2023, Gastroenterology

Claudio Fiocchi collaborates frequently with a range of co-authors, reflecting interdisciplinary and team-based research efforts. Frequent collaborators include Florian Rieder, Gail West, Sinan Lin, Pranab K. Mukherjee, and Ren Mao. These partnerships are often evident in joint publications related to inflammatory bowel disease and related gastrointestinal research.

Best Publications

  • Inflammatory bowel disease: Etiology and pathogenesis

    Claudio Fiocchi

  • Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation.

    Vincenzo Casini-Raggi;Lori Kam;Yoo Jin T Chong;Claudio Fiocchi

  • Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance

    Kenji Ina;Jugoh Itoh;Kouhei Fukushima;Kazuo Kusugami

  • Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis.

    Luca Pastorelli;Rekha R. Garg;Sharon B. Hoang;Luisa Spina

  • Ulcerative colitis and Crohn’s disease: distinctive gene expression profiles and novel susceptibility candidate genes

    Ian C. Lawrance;Claudio Fiocchi;Shukti Chakravarti

  • Angiogenesis as a novel component of inflammatory bowel disease pathogenesis

    Silvio Danese;Miquel Sans;Carol de la Motte;Cristina Graziani

  • VEGF-A Links Angiogenesis and Inflammation in Inflammatory Bowel Disease Pathogenesis

    Franco Scaldaferri;Stefania Vetrano;Miquel Sans;Vincenzo Arena

  • Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications.

    Silvio Danese;Carol de la Motte;Claudio Fiocchi

  • Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients

    Silvio Danese;Jeffry Katz;Simone Saibeni;Alfredo Papa

  • The emergence of inflammatory bowel disease in the Asian Pacific region

    Qin Ouyang;Rakesh Tandon;Khean Lee Goh;Choon Jin Ooi

  • Intestinal inflammation: a complex interplay of immune and nonimmune cell interactions

    Claudio Fiocchi

  • A murine model of Chronic inflammation-induced intestinal fibrosis down-regulated by antisense NF-κB

    Ian C Lawrance;Feng Wu;AndrÉ Z.A Leite;Joseph Willis

  • Enhanced leukocyte binding by intestinal microvascular endothelial cells in inflammatory bowel disease.

    DG Binion;GA West;K Ina;NP Ziats

  • Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease

    S Kugathasan;L J Saubermann;L Smith;D Kou

  • VEGF-C–dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease

    Silvia D’Alessio;Carmen Correale;Carlotta Tacconi;Alessandro Gandelli

  • Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients

    Silvio Danese;Carol de la Motte;Andreas Sturm;Jon D Vogel

  • Cutting edge: T cells trigger CD40-dependent platelet activation and granular RANTES release: a novel pathway for immune response amplification.

    Silvio Danese;Carol A De La Motte;Brenda M. Rivera Reyes;Miquel Sans

  • Inflammatory Bowel Disease: Autoimmune or Immune-mediated Pathogenesis?

    Zhonghui Wen;Claudio Fiocchi

  • TNF-α Blockade Down-Regulates the CD40/CD40L Pathway in the Mucosal Microcirculation: A Novel Anti-Inflammatory Mechanism of Infliximab in Crohn’s Disease

    Silvio Danese;Miquel Sans;Franco Scaldaferri;Alessandro Sgambato

  • The CD40/CD40L costimulatory pathway in inflammatory bowel disease

    S. Danese;M. Sans;Claudio Fiocchi

  • Critical role of the CD40–CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease

    Silvio Danese;F. Scaldaferri;S. Vetrano;T. Stefanelli

Frequent Co-Authors

Silvio Danese
Silvio Danese Vita-Salute San Raffaele University
Carol A. de la Motte
Carol A. de la Motte Cleveland Clinic
Subra Kugathasan
Subra Kugathasan Emory University
Rocio Lopez
Rocio Lopez Cleveland Clinic
John R. Goldblum
John R. Goldblum Cleveland Clinic
Gary W. Falk
Gary W. Falk University of Pennsylvania
Richard H. Duerr
Richard H. Duerr University of Pittsburgh
Gerhard Rogler
Gerhard Rogler University of Zurich
Charalabos Pothoulakis
Charalabos Pothoulakis University of California, Los Angeles
Pranab K. Mukherjee
Pranab K. Mukherjee Louisiana State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology but considering a broader healthcare focus, exploring nursing pathways like the easiest nurse practitioner program options can provide a flexible entry point. These programs often offer streamlined coursework for busy students aiming to advance their clinical expertise.

Mental health is another growing area linked to immunological research, especially regarding neuroimmune interactions. The online pmhnp programs with clinical placement highlight opportunities for psychiatric-mental health nurse practitioners to gain hands-on experience, which is critical for career success.

Cost remains a major factor for many students pursuing health-related degrees. Identifying the cheapest online pmhnp programs can make advanced education more accessible without compromising on quality, allowing more professionals to enter vital roles within healthcare and immunology-linked fields.

Finally, understanding financial outcomes is essential when choosing a career path. The dnp salary data provides valuable insights into expected earnings across states for Doctor of Nursing Practice graduates, helping guide decisions about specialization and geographic location.

Best Scientists Citing Claudio Fiocchi

Trending Scientists